title: Reply to the letter "Digoxin in patients with atrial fibrillation and heart failure: A risk factor or a marker of increased mortality".
authors.affiliation: Mount Sinai St. Luke's & Mount Sinai West Hospitals, New York, NY, USA. Electronic address: chiragpbavishi@gmail.com.
authors.forename: Chirag
authors.initials: C
authors.lastname: Bavishi
authors.affiliation: University of Louisville, Louisville, KY, USA.
authors.forename: Abdur Rahman
authors.initials: AR
authors.lastname: Khan
authors.affiliation: University of Alabama at Birmingham, Birmingham, AL, USA.
authors.forename: Sameer
authors.initials: S
authors.lastname: Ather
mesh_terms: D001281:Atrial Fibrillation / Q000188:drug therapy* / Q000453:epidemiology*; D004077:Digoxin / Q000008:administration & dosage*; D005260:Female; D006333:Heart Failure / Q000188:drug therapy* / Q000453:epidemiology*; D006801:Humans; D008297:Male
chemical_list: D004077:Digoxin
keywords: Atrial fibrillation; Digoxin; Heart failure